Pausing antithrombotic agents for colonoscopy was associated with higher odds of thromboembolic events after colonoscopy, particularly in patients with high underlying thromboembolic risk, in a single-center observational study in Hong Kong.
A dearth of real-world data related to post-polypectomy bleeding and thromboembolic (TE) events led researchers to conduct a retrospective cohort study of 6,220 consecutive patients who underwent colonoscopy at Queen Mary Hospital of Hong Kong between